← All trials

NCT04697940

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 15, 2020
Primary completion
Dec 30, 2021
Completion date
Dec 30, 2025
First posted
Jan 6, 2021
Last posted
Jan 6, 2021
Enrollment
30
Arms / groups
1 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.